Treatment

Displaying 1 - 10 of 351

Hologic's Cynosure division launches TempSure Envi

Hologic's Cynosure division launches TempSure Envi
Hologic's Cynosure division has announced the launch of TempSure Envi – an FDA-cleared advanced radiofrequency device that minimises facial fine lines and wrinkles, tightens skin through soft tissue coagulation, and improves the appearance of cellulite. TempSure Envi is a simpler way for patients to maintain beautiful skin. The device heats the deep layers of skin to regenerate collagen and improve the appearance of cellulite and wrinkles.
23rd January 2018

Centrifugal heart pump receives FDA 510k clearance

Centrifugal heart pump receives FDA 510k clearance
International Biophysics Corporation has announced they have received FDA 510k clearance for their FloPump 32 centrifugal disposable heart pump. The FloPump 32 is one of the smallest centrifugal pumps in the world at 32ml prime. The FloPump 32 is a single use, centrifugal heart pump designed and intended to be used in conjunction with the Maquet RotaFlow console.
22nd January 2018

Antibiotics can benefit from latest type of cellulose

Antibiotics can benefit from latest type of cellulose
Produced by plants, algae and some bacteria, cellulose is an abundant molecule involved in the production of hundreds of products, from paper to fabrics to renewable building materials. It’s also one starting material for producing ethanol, a common fuel additive and renewable fuel source. Now, Stanford scientists have found a new type of cellulose in bacteria with properties that could make it an improvement over traditional cellulose for fuels and other materials, or for better understanding and treating bacterial infections.
22nd January 2018


Non-opioid treatment option for people with chronic pain

Non-opioid treatment option for people with chronic pain
Boston Scientific has announced that the U.S. FDA has approved the Spectra WaveWriter Spinal Cord Stimulator (SCS) System. It is the first and only system approved by the FDA to simultaneously provide paresthesia-based and sub-perception therapy. The system allows physicians and patients to combine therapeutic options, customise therapy and capture real-time feedback designed to treat chronic and debilitating pain successfully.
17th January 2018

Growing patient-specific T cells could aid immunotherapies

Growing patient-specific T cells could aid immunotherapies
Immunologists and oncologists are harnessing the body’s immune system to fight cancers and other diseases with adoptive cell transfer techniques. In a normal immune response, a type of white blood cell known as T cells are instructed by another kind of immune cell called an antigen-presenting cell (APC) to expand their numbers and stay alive.
17th January 2018

Providing insight into anti-inflammatory drug candidate

Providing insight into anti-inflammatory drug candidate
  One of the most important and fraught processes in the human body is inflammation. Inflammatory responses to injury or disease are crucial for recruiting the immune system to help the body heal, but inflammation can also cause dangerous blood clots and other conditions by inducing an overproduction of the coagulant protein thrombin.
16th January 2018

The coming of age of gene therapy

The coming of age of gene therapy
After three decades of hopes tempered by setbacks, gene therapy—the process of treating a disease by modifying a person’s DNA—is no longer the future of medicine, but is part of the present-day clinical treatment toolkit. The journal Science provides an in-depth and timely review of the key developments that have led to several successful gene therapy treatments for patients with serious medical conditions.
15th January 2018

ZOLL's portfolio of defibrillators receive premarket approval

ZOLL's portfolio of defibrillators receive premarket approval
  ZOLL has announced that it is the first company to achieve premarket approval (PMA) by the FDA to continue to market and distribute its full line of defibrillators in the U.S. The list of defibrillators that received PMA approval include the R Series and X Series monitor/defibrillators and the AED Pro and AED Plus automated external defibrillators.
15th January 2018

Improving wound healing with mechanical forces

Improving wound healing with mechanical forces
To most, an operating room and a manufacturing plant are as different as any two places can be. But not to Dennis Orgill. “To some degree when you do an operation it’s much like manufacturing something in a factory,” explains Orgill SM ’80, PhD ’83, who serves as medical director at Brigham and Women’s Hospital’s Wound Care Center and as a professor at Harvard Medical School.
11th January 2018

Increasing the accessibility of vision care in developing world

Increasing the accessibility of vision care in developing world
Vision impairment is a major global issue. More than 2 billion people worldwide don’t have access to corrective lenses. Getting eyeglasses prescriptions is especially difficult in developing countries. Optometrists are generally located in urban centers and rarely see patients from rural areas, so many people suffer from uncorrected impairments. According to the World Health Organisation, this can lead to impaired quality of life, learning difficulties, and lost employment opportunities and finances.
11th January 2018


Treatment documents


Sign up to view our publications

Sign up

Sign up to view our downloads

Sign up

Building IoT products for smart healthcare market
8th February 2018
United Kingdom Cocoon Networks, London
Medical Japan 2018
21st February 2018
Japan INTEX Osaka
Med-Tech Innovation Expo 2018
25th April 2018
United Kingdom Ricoh Arena, Coventry